Navigation Links
Mini MONOKA

ProductsMini MONOKA
Company FCI Ophthalmics Inc.
Item Mini MONOKA
Features 
Description For canalicular laceration involving external 2/3 of one canaliculus. Medical grade silicone. Box of 3, sterile. Note: For safe and proper insertion of the punctum plug above, we recommend the use of disposable insertion devices # S1-3090u.
Info FCI Ophthalmics Inc.Call FCI Ophthalmics Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-502-7279

Customer Service: 1-800-932-4202
Web site: http://www.fci-ophthalmics.com

Related medicine products :

1. Self-Threading MONOKA (Fayet-Bernard Ritleng Type, PVP coating)
2. Wide Collarette MONOKA (4mm)
3. Med. Collarette MONOKA (3mm)
4. Self-Threading MONOKA (Fayet-Bernard Ritleng Type, 3 mm COLLARETTE)
5. Self-Threading MONOKA (Fayet-Bernard Ritleng Type, 4 mm COLLARETTE)
TAG: Mini MONOKA
NIVEA body Good-bye Cellulite Gel-Cream visibly reduces the appearance of cellulite.
Safe-Wrap tubes are heparinized glass capillary devices wrapped in a puncture-resistant film. These tubes are used for the collection of capillary blood samples for the measurement of pH, blood gases
...le off white, moist, tough but flexible flat sheet... elastin fibres presented moist in sterile saline....ouble vacuum packed aluminium foil/polyethylene sa...ilised by gamma irradiation. Porcine dermal collag...
Safe-Wrap Combo Blood Collection Tubes are used for the collection of capillary blood samples for use with i-STAT blood gas, electrolyte, and chemistry cartridges requiring either 95 L or 65 L of sam
Medicine Products:
(Date:8/20/2008)...PRNewswire/ -- Questex Media Group, Inc., a,global...nd owner of,American Spa and American Salon magazi...uty Shows, the International Esthetics, Cosmetics ...nt events today announced the,acquisition of SpaTr...ttp://www.SpaTrade.com ) and SpaExec ( http://ww...
(Date:8/20/2008)...surance market ranked 156 among fastest growing ... list, BETHESDA, Md., Aug. 20 /PRNewswire/ -- Int...ife insurance market, announced today that it has,...ted company in the US by,Inc. magazine. The compan...,fastest growing companies in America, having expe...
(Date:8/20/2008)...20 /PRNewswire/ -- WXYZ- TV/Channel 7 and The,Detr...ll give thousands of,Detroit metro area children a...DS" program. This year the program will be held Su...e Charles H. Wright Museum of African,American His... for Kids",has provided free immunizations to over...
(Date:8/20/2008)...wswire/ -- Fourteen physicians who have been,part ...they plan to enhance,the care and service they pro...re., "These are top-notch primary care physicians...ur organization," said Nick Turkal, M.D., Aurora,s...orward to working with,them to support their care ...
Breaking Medicine News(10 mins):Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:Integrity Capital Partners Ranked 2nd Fastest Growing Insurance Related Company in US by Inc. Magazine 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2
...ound that the Schering-Plough fungus-fighter drug ... better than older drugs in protecting patients wi...es financed by the company. The results of their ...d Journal of Medicine. Apart from preventing fun...
...he series of release of Software Tools and Fonts i...//the Department of Information Technology (DIT), ... and fonts in as many as seven Indian Languages fo...ri.Maran, Minister of Communications & Information...
...eneral of the World Health Organization, Dr. Marga... pandemics currently threatening mankind.// Dr. C...th enough effort and political will anything is po...ed last week depict that deaths from measles have ...
...creating a website for the patients for publishing...ill be able to "review" the performance of their G...ings of their GPs, thereby helping others to decid...The Department of Health said that the aim is to i...
Other Medicine News:Health News:Software Tools & Fonts in Seven Indian Languages 2
(Date:8/18/2008)...swire-FirstCall/ -- Oramed,Pharmaceuticals, Inc. (...oper,of oral delivery systems, announced today tha...ss the Safety, Pharmacokinetics (PK) and,Pharmacod...Healthy,Subjects," has been chosen for presentatio...ean Association for the Study of Diabetes (EASD) i...
(Date:8/18/2008)...ently in Phase I -, PRINCETON, N.J. and SAN DIEGO..., a clinical stage biotechnology company committed...e-threatening and life-altering,infectious disease...1,772,B2 by the U.S. Patent and Trademark Office, ...rently in Phase I development for the treatment of...
(Date:8/15/2008)...-- Globus Medical, Inc., the largest,privately hel...announced,that the first FLEXUS(TM) Interspinous S...l Device Exemption ("IDE") recently granted to Glo..., The FLEXUS(TM) Spacer is placed with a unilater...imal disruption to the surrounding musculature,and...
(Date:8/14/2008)...e-FirstCall/ -- Pharmasset, Inc.,(Nasdaq: VRUS ),... to,discovering, developing and commercializing no...dited financial results for the third fiscal,quart...loss attributable to,common stockholders of $15.0 ...ter ended June 30, 2008, as compared to a net loss...
Breaking Medicine Technology:Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome) 2First FLEXUS(TM) Interspinous Spacer Surgeries for IDE Clinical Trial 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 2Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 3Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 4Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 5Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 6Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 7Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 8Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 9ACSM and AMA Launch Exercise Is Medicine Program 5507 1ACSM and AMA Launch Exercise Is Medicine Program 5507 2ACSM and AMA Launch Exercise Is Medicine Program 5507 3Multi talented Entertainer Chris Brown Goes Back to School Taking on a Starring Role in the St Jude Math A Thon 28R 29 Video 5502 1Multi talented Entertainer Chris Brown Goes Back to School Taking on a Starring Role in the St Jude Math A Thon 28R 29 Video 5502 2IdentiGENs DNA TraceBack 28R 29 Receives USDA Process Verified Program Approval 5497 1IdentiGENs DNA TraceBack 28R 29 Receives USDA Process Verified Program Approval 5497 2IdentiGENs DNA TraceBack 28R 29 Receives USDA Process Verified Program Approval 5497 3Blood incompatible infant heart transplants safe may save more lives 5492 1Blood incompatible infant heart transplants safe may save more lives 5492 2
...n Colorectal Cancer,and in Hormone-Refractory Pros..., June 01, 2007,/PRNewswire-FirstCall/ -- Poniard ...y focused on oncology, today announced,promising r...e 1,dose-escalating trials of picoplatin, a new ge...atment of metastatic colorectal cancer,(CRC) and m...
...Pharmaceuticals Inc.,(TSX: TLN) announced today th...rial investigating ECO-4601 in advanced cancer,pat...e American,Society of Clinical Oncology (ASCO) Ann...ose escalation portion of the study, 14,patients (...glioma), that had completed and not responded to t...
Other Medicine Technology:Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 2Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 3Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 4Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 5Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers 6Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 2Thallion Announces Publication of ECO-4601 Phase I/II Clinical Data,at ASCO 3